S48 Lenzilumab efficacy and safety in newly hospitalized Covid-19 subjects: results from the LIVE-AIR phase 3 randomized double-blind placebo-controlled trial
Z. Temesgen, C. Burger, J. Baker, C. Polk, C. Libertin, C. Kelley, VC Marconi, R. Orenstein, VM Catterson, W. Aronstein, C. Durrant, D. Chappell, O. Ahmed, G. Chappell, A. Badley
{"title":"S48 Lenzilumab efficacy and safety in newly hospitalized Covid-19 subjects: results from the LIVE-AIR phase 3 randomized double-blind placebo-controlled trial","authors":"Z. Temesgen, C. Burger, J. Baker, C. Polk, C. Libertin, C. Kelley, VC Marconi, R. Orenstein, VM Catterson, W. Aronstein, C. Durrant, D. Chappell, O. Ahmed, G. Chappell, A. Badley","doi":"10.1136/thorax-2021-btsabstracts.54","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":114929,"journal":{"name":"Developing treatments for COVID-19","volume":"12 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2021-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Developing treatments for COVID-19","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1136/thorax-2021-btsabstracts.54","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
